Sirolimus for endometrial neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 Aug 2023: Trial registered, NCT05997017
  2. 28 Dec 2023: Trial started, NCT05997017

The trials

NCT05997017: Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

State
Under way
Phase
Phase 2
People
29 planned
Started
28 Dec 2023
Primary completion
Dec 2026
Arms
Endometrioid Endometrial Cancer
Results
None posted
  1. 18 Aug 2023: Trial registered
  2. 28 Dec 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Fyarro, Hyftor, Rapalimus, Rapamune, Scomara, Sirolimus (SIR).

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.